Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes

被引：0
|
作者：
Joep van der Leeuw
Frank L. J. Visseren
Mark Woodward
Yolanda van der Graaf
Diederick E. Grobbee
Stephen Harrap
Simon Heller
Giuseppe Mancia
Michel Marre
Neil Poulter
Sophia Zoungas
John Chalmers
机构：
[1] University Medical Centre Utrecht,Department of Vascular Medicine
[2] University of Sydney,The George Institute for Global Health
[3] University of Oxford,The George Institute for Global Health, Nuffield Department of Population Health
[4] University Medical Centre Utrecht,Julius Centre for Health Sciences and Primary Care
[5] University of Melbourne,The Royal Melbourne Hospital
[6] University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust,Istituto Auxologico Italiano
[7] University of Milano-Bicocca,International Centre for Circulatory Health
[8] Hôpital Bichat-Claude Bernard and Université Paris 7,undefined
[9] Imperial College,undefined
来源：
Diabetologia | 2016年 / 59卷
关键词：
Glycaemic target; Hypoglycaemia; Net benefit; Personalised medicine; Type 2 diabetes; Vascular complications;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2603 / 2612
页数：9
相关论文
共 50 条
  • [1] Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
    van der Leeuw, Joep
    Visseren, Frank L. J.
    Woodward, Mark
    van der Graaf, Yolanda
    Grobbee, Diederick E.
    Harrap, Stephen
    Heller, Simon
    Mancia, Giuseppe
    Marre, Michel
    Poulter, Neil
    Zoungas, Sophia
    Chalmers, John
    DIABETOLOGIA, 2016, 59 (12) : 2603 - 2612
  • [2] Intensive glucose control in patients with type 2 diabetes
    Hey-Hadavi, JH
    Tuck, C
    Solowiejczyk, J
    Almeida, K
    Goland, RS
    DIABETES, 1999, 48 : A348 - A349
  • [3] Intensive glucose control in patients with type-2 diabetes
    Pavlicek, V.
    DIABETOLOGE, 2008, 4 (07): : 557 - 558
  • [4] Is an intensive glycaemic control beneficial in diabetes type 2?
    Rakowitz, Bettina
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (39) : 1940 - 1940
  • [5] Intensive glucose control in type 2 diabetes
    Luan, Fu L.
    Nguyen, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (14): : 1519 - 1520
  • [6] Intensive glucose control and risk of cancer in patients with type 2 diabetes
    G. Stefansdottir
    S. Zoungas
    J. Chalmers
    A. P. Kengne
    M. J. Knol
    H. G. M. Leufkens
    A. Patel
    M. Woodward
    D. E. Grobbee
    M. L. De Bruin
    Diabetologia, 2011, 54 : 1608 - 1614
  • [7] Intensive glucose control and risk of cancer in patients with type 2 diabetes
    Stefansdottir, G.
    Zoungas, S.
    Chalmers, J.
    Kengne, A. P.
    Knol, M. J.
    Leufkens, H. G. M.
    Patel, A.
    Woodward, M.
    Grobbee, D. E.
    De Bruin, M. L.
    DIABETOLOGIA, 2011, 54 (07) : 1608 - 1614
  • [8] Intensive glucose control and risk of cancer in patients with type 2 diabetes
    Stefansdottir, G.
    Zoungas, S.
    Chalmers, J.
    Kengne, A. P.
    Knol, M. J.
    Leufkens, H. G. M.
    Patel, A.
    Woodward, M.
    Grobbee, D. E.
    De Bruin, M. L.
    DIABETOLOGIA, 2013, 56 (09) : 2105 - 2106
  • [9] Effects of Intensive Blood Glucose Control on Quality of Life in Elderly Patients with Type 2 Diabetes
    Zhang, Qiu
    Zhang, Nan
    Hu, Hong-Lin
    He, Yong
    Cheng, Ming-Wei
    Wang, Xiu-Yan
    Yang, Mind-Gong
    DIABETES, 2010, 59 : A136 - A136
  • [10] Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus
    Camacho, P
    Pitale, S
    Abraira, C
    DRUGS & AGING, 2000, 17 (06) : 463 - 476
12345